The BPH and PCa patients had both patterns of PSA glycan profiles (pattern 1 and 2); whereas high-risk PCa patients, but not low-risk/intermediate-risk PCa patients, had pattern 2 glycan profiles (Figure 3). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.